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Jadelle is a set of two flexible cylindrical implants 
c o n s i s t i n g  o f  a  
dimethylsiloxane/methylvinylsiloxane copolymer 
core enclosed in thin-walled silicone tubing. Each 
rod contains 75 mg of the progestin levornogestrel. 
The core of each rod is a mixture, half of 
levornogestrel, half of the elastomer. The rods are 
sealed with polydimethylsiloxane adhesive and 
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ABSTRACT
Background: Jadelle is a set of two flexible cylindrical implants consisting of a dimethylsiloxane/ 
methylvinylsiloxane copolymer core enclosed in thin-walled silicone tubing. It is an improved version of 
Norplant.  Worldwide, it is found to be effective, safe, reversible and convenient for many users.
Objective: To determine the acceptance rate, the Socio-demographic profile of the clients, post insertion 
complications and reason for discontinuation of the method among its acceptors in Aminu Kano Teaching 
Hospital, Kano.
Study design: This is a retrospective descriptive study, involving all acceptors of Jadelle Subdermal implant 
in the family planning unit of Aminu Kano Teaching Hospital Kano, North western Nigeria.
Results: A total of 1505 clients accepted contraceptive methods during the study period. Out of these, 102 had 
Jadelle inserted, giving a rate of 6.8%. All the clients who accepted Jadelle had it inserted for child spacing. 
The mean age of the clients at insertion was 28.9 years ± 6.1, the mean parity at insertion was 3.3± 1.8, while 
the mean weight at insertion was 63Kg ±11.4.  
About 94% of the clients had secondary and tertiary education. 42.2% of the clients had used a modern 
contraceptive method previously while the remaining 57.8% were using a modern method for the first time. 
Nine clients reported post insertion complication, pain at the site of insertion was reported by three clients, and 
pruritus was reported by one client and intermenstrual bleeding by five of the clients. Five women 
discontinued the method; 3(60%) was due to menorrhagia.
Conclusion: The continuation rate of the method is high (95.1%). Majority of the acceptors (98%) had formal 
education, only 2% of the acceptors were illiterate. Public enlightenment will improve its use among the non 
literate women. Keywords: Jadelle, Subdermal implant, Kano, Northern Nigeria
INTRODUCTION
sterilized. Each rod is approximately 2.5 mm in 
1
diameter and 43 mm in length
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weight gain; which are common with progestin only 
5contraceptives.
The objectives of this study is to determine the 
acceptance rate, the socio-demographic profile and 
post insertion complications among clients using this 
method of contraception in our centre and to report 




Aminu Kano Teaching Hospital, Kano is one of the 
tertiary/ referral health facilities for Kano and its 
environs.  It is a 500 bed hospital established in 1988. 
Located in Kano, the largest commercial centre of 
Northern Nigeria. This hospital receives clients from 
within Kano and neighbouring states of Bauchi, 
Katsina, Jigawa, Kaduna and Zamfara. The hospital 
has sixteen (16) departments. The clinical 
departments are Obstetrics and Gynaecology, 
Surgery,  Internal  medicine,  Paediatr ics ,  
Oph tha lmology,  Or thorh ino la ryngo logy,  
Anaesthesia and family Medicine.  The Para clinical 
departments include; haematology and blood bank, 
microbiology, histopathology, chemical pathology, 
radiology, physiotherapy, community medicine and 
the pharmacy. The hospital operates family planning 
clinics five days a week seeing an average of 40 
clients per day.
Study Design/Study Population
This study was a retrospective descriptive study. All 
clients who had Subdermal Jadelle implant inserted 
at the family planning clinic of Aminu Kano 
Teaching Hospital between January 2011 and 
December 2012 formed the study population. The 
case files of the clients accepting the method in the 
centre were retrieved. Socio-demographic data, 
previous method of contraception, post insertion 
complications and reasons for discontinuation of the 
Jadelle is a progestin-only product and does not 
contain oestrogen. The sole active ingredient in the 
rods is levornogestrel.  It has a molecular weight of 
312.45. Medical grade silicone rubber materials, 
including the type used in Jadelle, have been 
employed in various implantable devices for humans 
.2
since 1950
The levornogestrel in Jadelle is released at an initial 
rate of about 100 ìg/day at one month, declining to 
about 40 ìg/day at 12 months and to about 30 ìg/day 
at 24 months, stabilizing thereafter at about 30 
ìg/day. This rate of release results in sufficiently 
high plasma levels of the progestin to inhibit 
ovulation and provide effective contraception for up 
1, 2
to five years.
Jadelle rods can be inserted just below the skin of the 
woman's inner upper arm through a small incision 
made either with a scalpel or a disposable pre-loaded
inserter. The two rods are placed in the shape of a V 
opening toward the shoulder. Strict asepsis must be 
observed to avoid infection. Training of health care 
providers is essential for proper placement and 
removal. The better the placement, the easier 
2
removals will be .
The annual pregnancy rate per 100 users was 0.1 at 
one, two, and three years, 0.0 at four years, and 0.8 at 
five years. The Pearl Index pregnancy rate was less 
3
than 0.2 pregnancies per hundred woman-years.
Adverse events that have been reported include, 
irregular menstrual bleeding in the form of prolonged 
episodes of bleeding or spotting, heavy bleeding, 
bleeding or spotting between periods, no bleeding at 
all for several months or a combination of these 
4
patterns,  fortunately, for  most women , these 
menstrual irregularities will diminish gradually with 
5
continuing use.
Other adverse events reported in 10% of women in 
the Jadelle clinical trials were pain, discolouration or 
other skin reactions at the site of implant, dizziness, 
leucorrhoea, mastalgia, nausea, pelvic pain and 
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twenty four hours and return of fertility almost 
6immediately after its removal . Annual pregnancy 
rates following typical use of Jadelle is 0.24per 100 
7woman years . None of the acceptors in this study 
reported pregnancy during its use.
Common side effects of implants which could limit 
its acceptability are disruption of menstrual cycle. 
These include menorrhagia, spotting between 
6periods and oligomenorrhoea . Amenorrhoea may 
also occur in about 20-30 % of levornogestrel 
implant users compared to 30-40% of etornogestrel 
6(implanon) users . In our study, the complicatios 
reported are pain at the site of insertion was reported 
by three (3%) clients, pruritus by one(1%) client and 
intermenstrual bleeding by five(5%) of the clients.
The mean age and parity of the clients in this study 
were 28.9±6.1 and 3.3±1.8; these figures are 
comparable to 33.81 and 4.05 reported from a similar 
5study in Portharcout . The mean age of the clients in 
this study is also comparable to 27.2±5.2 in a study in 
the United States; however the mean parity in our 
study of 3.3±1.8 is higher than 1.4 obtained in the 
8United States study . This is probably due to higher 
parity of women in our environment compared to 
United States. The mean weight of the women at 
insertion of the implant was 63Kg ±11.4; this is 
9comparable to 56.6±9.6 reported from Bangkok  and 
1056.1±9.2 reported in Mexico  Weight
 evidence that body 
weight affects the efficacy of implants and in our 
study, weight gain did not pose a problem with the 
clients. Although clinical trials of this method 
included relatively few women who weighed>90 Kg, 
hence the effect of increased body weight on efficacy 
is unknown. Serum levels of implants are inversely 
related to the body weight and decreased with time 
11after insertion . This aspect of levornogestrel 
 gain was not a 
problem in our study, because only one client 
discontinued the method due to this reason. 
Weight was not a barrier to offering Jadelle in our 
unit. This is because; there is no
method were obtained. None of the client reported 
been pregnant while using the implant. Analysis was 
done using absolute number and percentages. 
RESULTS
A total of 1505 clients accepted contraceptive 
methods during the study period. Out of these, 102 
had Jadelle inserted, giving a rate of 6.8%. All the 
clients who accepted Jadelle had it inserted for child 
spacing. The mean age of the clients at insertion was 
28.9 years ± 6.1, the mean parity at insertion was 3.3± 
1.8, while the mean weight at insertion was 63Kg 
±11.4. There was no significant weight gain during 
follow up.
About 89% of the clients had secondary and/or 
tertiary education. Four percent had only primary 
education, and another 5% had only Islamic 
education. The remaining 2% were not literate.
Forty two percent of the clients had used a modern 
contraceptive previously; the remaining 58% were 
using a modern contraceptive method for the first 
time.
Nine of the clients had post insertion complication. 
Pain at the site of insertion was reported by three 
clients, pruritus by one client and intermenstrual 
bleeding by five of the clients.
Five women discontinued the method; three of these 
(60%) were due to menorrhagia. Those that 
discontinue the method are below the age of thirty 
and of parity less than five.
DISCUSSION:
Acceptors of Jadelle constituted 6.8% of all new 
users within the study period. This is higher than 
5
0.95% reported in a similar study in Port Harcourt . 
The acceptance rate is however lower than 12.5% 
reported for Norplant in Lagos.
The key advantages of contraceptive implant are its 
effectiveness, convenience, safety, long term 
contraceptive protection that commence within 
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95.1%, which is comparable to 98.9% obtained by 
11other workers
In conclusion, the acceptance rate of Jadelle was 
6.8% of all new users within the study period.  The 
continuation rate of the contraceptive implant is high 
(95.1%). Ninety one percent of the acceptors had 
secondary/tertiary education. Public enlightenment 
on its efficacy and safety will improve its acceptance 
among the illiterate women.
implants efficacy should be discussed when 
counselling overweight women.
The mean number of living children of the clients in 
this study is 3.1±1.7 this is similar to 2.0±0.9 
10
obtained in a study in Mexico . 
Fifty six percent (56%) of the clients in this study had 
been on other form of contraception while the 
remaining 44% were taking a contraceptive method 
for the first time. The proportion of those taking 
contraception for the first time in this study was 
10 11
higher than 11%  and 20.6%  reported by other 
workers. This could be due to campaign on the 
efficacy and safety of the method during the 
antenatal health talk and counselling in the family 
planning clinic.
Majority of the clients (89%) had secondary and/or 
tertiary education, 5% had Islamic education, and 4% 
had primary education, while 2% were non literate. 
This is comparable to 75.8% who had secondary 
11
and/or tertiary education in Jos . The findings 
contrast however with the findings in Bangkok study 
were majority of the clients (71.4%) had primary 
education, 21.4% had secondary education and 4.3 
9
had Vocational education . The low proportion of the 
non literate and those with Islamic and primary 
education among the acceptors in this study could be 
due to aversion to western oriented programs in our 
setting.
Nine percent of the clients had post insertion 
complication. Three of these had pain, and five had 
intermenstrual bleeding. This is comparable to 
12
findings by other workers .
Five clients discontinued the method, three (60%) of 
these were due to menorrhagia, this is comparable to 
57.5% of women removing implants due to 
1
menstrual disturbance in Jos , but lower than 78.6% 
13
in Northern Ethiopia.  One (20%) of the client 
discontinued the implant because of weight gain, this 
is lower than 35.7% reported in Northern 
13
Ethiopia. The continuation rate in this study was 
Table 1: Sociodemographic profile of the clients 

































Age range= 18-49        mean age 28.9±6.1  
b. Parity
1-5                                                    
       6-10
Total 
Parity range= 1 -10,    mean  parity 3.3±1.8
 



























Table 2: Educational level of clients accepting 
Jadelle
Educational level         Frequency            percentage  
None                                  2                             2  
Primary                              4                             4  
Secondary                          40                          39  
Tertiary                              51                          50  
Islamic                               5                             5  
Total                                  102                       100  
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Table 3: post insertion complication
Post Insertion Complication Frequency         Percentage
None                         
                         
93                      91
Pain                                                    3                        3
Pruritus                                              1                         1  
Intermenstrual bleeding                     5                        5
Total                   102                    100
Table 4. Reasons for Discontinuation 
Reasons For Discontinuation  Frequency  Percentage  
Menorrhagia  3  60  
Weight Gain  1  20  
Divorced  1  20  
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